Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guo-Ming Shi

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 20, 2023
Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitmentZheng Gao, Shan-Ru Feng, Jia-Feng Chen, et al.
International Immunopharmacology|July 26, 2023
Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinomaZheng Gao, Xiao-Gang Li, Shan-Ru Feng, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2008
Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentialsGuo-Ming Shi, Yang Xu, Jia Fan, et al.
Cell Death & Disease|February 2, 2023
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axisXiao-Jun Guo, Xiao-Yong Huang, Xuan Yang, et al.
Surgical Endoscopy|September 8, 2022
Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysisDan-Jun Song, Kai Zhu, Jin-Peng Tan, et al.
Cell Death & Disease|December 14, 2017
Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinomaNan Xie, Jia-Bin Cai, Lu Zhang, et al.
Plos One|October 15, 2011
Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantationJie Hu, Zheng Wang, Jia Fan, et al.
Oncotarget|January 13, 2016
Generation and characterization of a tetraspanin CD151/integrin α6β1-binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCCAi-Wu Ke, Peng-Fei Zhang, Ying-Hao Shen, et al.
Hepatology (Baltimore, Md.)|May 23, 2015
Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transitionZhi-Chao Wang, Qiang Gao, Jie-Yi Shi, et al.
Cancer Letters|July 6, 2026
FGFR2 Fusion-Driven CXCL3 Downregulation Attenuates Neutrophil Recruitment in Intrahepatic CholangiocarcinomaTao Zhu, Jia-Cheng Lu, Yan-Zi Pei, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 20, 2023
Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitmentZheng Gao, Shan-Ru Feng, Jia-Feng Chen, et al.
International Immunopharmacology|July 26, 2023
Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinomaZheng Gao, Xiao-Gang Li, Shan-Ru Feng, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2008
Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentialsGuo-Ming Shi, Yang Xu, Jia Fan, et al.
Cell Death & Disease|February 2, 2023
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axisXiao-Jun Guo, Xiao-Yong Huang, Xuan Yang, et al.
Surgical Endoscopy|September 8, 2022
Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysisDan-Jun Song, Kai Zhu, Jin-Peng Tan, et al.
Cell Death & Disease|December 14, 2017
Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinomaNan Xie, Jia-Bin Cai, Lu Zhang, et al.
Plos One|October 15, 2011
Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantationJie Hu, Zheng Wang, Jia Fan, et al.
Oncotarget|January 13, 2016
Generation and characterization of a tetraspanin CD151/integrin α6β1-binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCCAi-Wu Ke, Peng-Fei Zhang, Ying-Hao Shen, et al.
Hepatology (Baltimore, Md.)|May 23, 2015
Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transitionZhi-Chao Wang, Qiang Gao, Jie-Yi Shi, et al.
Cancer Letters|July 6, 2026
FGFR2 Fusion-Driven CXCL3 Downregulation Attenuates Neutrophil Recruitment in Intrahepatic CholangiocarcinomaTao Zhu, Jia-Cheng Lu, Yan-Zi Pei, et al.
Pageof 10